Finding a Legitimate Mounjaro Stockist in the UK

What the clinical evidence tells us about why stock pressure exists

The SURMOUNT-1 trial, published in the New England Journal of Medicine, randomised 2,539 adults with obesity and followed them for 72 weeks. Participants on tirzepatide 15mg lost an average of around 20–21% of body weight. Those are numbers that had not been seen from a licensed weight-management medicine before, and clinicians noticed. NICE's formal recommendation of tirzepatide in December 2024 (TA1026) then opened a structured NHS pathway (phased by BMI and comorbidities) which added another wave of demand on top of the already-busy private market.

The result is that genuine stock moves quickly. Pharmacies sourcing through the licensed UK supply chain (via Eli Lilly's authorised distribution network) do carry all six pen strengths (2.5 mg through to 15 mg), but availability at any specific dose can tighten without warning. You can read more about the broader Mounjaro stock situation in the UK if you are mid-treatment and concerned about continuity.

That context matters here because scarcity is the environment in which counterfeit products thrive. The MHRA raided the first illicit UK manufacturing site producing fake tirzepatide pens in Northampton in October 2025. Fake pens have, in other cases, been found to contain insulin, a genuinely dangerous substitution. Urgency about supply should never push you toward an unverified seller.

What a compliant Mounjaro stockist actually looks like

In the UK, a lawful Mounjaro stockist is a GPhC-registered pharmacy that dispenses only against a valid prescription, written by a licensed prescriber who has clinically assessed the patient. That assessment must happen before dispensing, not as a formality, but as a real clinical review. The GPhC pharmacy register is publicly searchable; pulling it up and typing in a pharmacy's name takes less than a minute and is the single quickest thing you can do to check whether a supplier is legitimate. If they do not appear, stop there.

There are other signs worth knowing. A genuine stockist will ask for full medical history, current medications and, in many responsible services, photo-ID verification and a live weight check. They will notify your GP in line with GPhC guidance. They will not offer the medicine without those steps. Sellers who advertise Mounjaro on social media, offer it at prices well below the current market range, or promise to send it without any clinical consultation are not operating within the law, and the product they send may not be what the label says.

The MHRA Drug Safety Updates index carries the detail on enforcement action if you want to read further. Suspected illegal sellers can also be reported via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Mounjaro stockists and the difference between NHS and private supply

There are two legitimate routes to a licensed Mounjaro stockist. The NHS route runs through the phased rollout described in NICE TA1026: from June 2025, adults with a BMI of 40 or above and four or more qualifying conditions (which include high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease and type 2 diabetes) can be prescribed tirzepatide through the NHS, with GP practices able to join from April 2026. Meeting the criteria does not guarantee immediate access, waiting times and practice participation vary.

The private route does not require a referral or a waiting list, but it still requires a prescription following genuine clinical assessment. Private stockists include GPhC-registered online pharmacies whose prescribers review each patient individually. If you want to understand more about what tirzepatide is and how it works before going further, the tirzepatide overview covers the clinical background in detail, and you can also explore the full Mounjaro treatment page for UK-specific information on eligibility and how the pen works in practice.

On the question of cost: private pricing rose after Eli Lilly's September 2025 list-price change, with monthly costs now ranging roughly £149–£375 depending on dose and provider. The Eli Lilly Mounjaro price increase page explains what drove that change and what it means in practice. What headline prices often do not include is the consultation fee, prescription charge, delivery cost and any ongoing aftercare, it is worth reading the small print before comparing figures between stockists.

How to approach a stockist safely, and what comes next

Once you have confirmed a pharmacy is GPhC-registered, the next thing to look at is their clinical process. Do they review every order individually, or do they use automated approvals? Do they have prescribers reachable for questions after you start? Do they tell your GP? These are the questions that separate a responsible stockist from one that treats the prescription as a formality. Some people also ask whether it is possible to stockpile Mounjaro to guard against future shortages; that is a question worth reading through carefully, because the clinical answer is more nuanced than it might seem.

If you are already on treatment and thinking about stopping, the guidance on stopping Mounjaro is worth reviewing before you make any changes, titration decisions belong with your prescriber, not with stock availability. And if you are still at the stage of deciding whether treatment is right for you, the weight-loss treatment overview sets out the landscape honestly, including what lifestyle changes work alongside any medicine.

At nume, our GPhC-registered pharmacy sources Mounjaro through the licensed UK supply chain. Every order is reviewed by a named prescriber, a real clinician, reading your answers the same day. If you are ready to find out whether you are clinically suitable, a free consultation is the right place to start.